[
  {
    "ts": null,
    "headline": "Wall Street Rebounds After Friday's Equity Sell-Off; Traders Await More Earnings Reports",
    "summary": "US equities rallied on Monday, reversing Friday's losses that followed disappointing jobs data, as t",
    "url": "https://finnhub.io/api/news?id=d711a94547f949d48e80a6a5c2f1b614d8101c0a0aad9473af615e7bb5883811",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754341125,
      "headline": "Wall Street Rebounds After Friday's Equity Sell-Off; Traders Await More Earnings Reports",
      "id": 136205733,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "US equities rallied on Monday, reversing Friday's losses that followed disappointing jobs data, as t",
      "url": "https://finnhub.io/api/news?id=d711a94547f949d48e80a6a5c2f1b614d8101c0a0aad9473af615e7bb5883811"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Dow jumps 580 points, S&P 500, Nasdaq have best day since May as Wall Street bounces back",
    "summary": "US stock futures were little changed following a week of sharp declines.",
    "url": "https://finnhub.io/api/news?id=d7031e48339cfb419465d37d7c98ee77b73339936c0d4fcad218522fa76f3f52",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754337623,
      "headline": "Stock market today: Dow jumps 580 points, S&P 500, Nasdaq have best day since May as Wall Street bounces back",
      "id": 136205621,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "US stock futures were little changed following a week of sharp declines.",
      "url": "https://finnhub.io/api/news?id=d7031e48339cfb419465d37d7c98ee77b73339936c0d4fcad218522fa76f3f52"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Companies' Earnings Growth Largely Steady as Revenue Expansion Accelerates, Oppenheimer Says",
    "summary": "S&P 500 companies' latest quarterly results showed the pace of earnings growth holding largely stead",
    "url": "https://finnhub.io/api/news?id=3caf5b64331c7c7aadb5859f1f80fb6cba5d0e1038a3621c7bb00eab291525ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754328549,
      "headline": "S&P 500 Companies' Earnings Growth Largely Steady as Revenue Expansion Accelerates, Oppenheimer Says",
      "id": 136200223,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "S&P 500 companies' latest quarterly results showed the pace of earnings growth holding largely stead",
      "url": "https://finnhub.io/api/news?id=3caf5b64331c7c7aadb5859f1f80fb6cba5d0e1038a3621c7bb00eab291525ee"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Dow jumps 500 points, S&P 500, Nasdaq rally in bounce back from Friday sell-off",
    "summary": "US stock futures were little changed following a week of sharp declines.",
    "url": "https://finnhub.io/api/news?id=c8751049844aab7772358d4225b974f63f3ed1586e2b198a108c893ce4405483",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754323897,
      "headline": "Stock market today: Dow jumps 500 points, S&P 500, Nasdaq rally in bounce back from Friday sell-off",
      "id": 136200201,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "US stock futures were little changed following a week of sharp declines.",
      "url": "https://finnhub.io/api/news?id=c8751049844aab7772358d4225b974f63f3ed1586e2b198a108c893ce4405483"
    }
  },
  {
    "ts": null,
    "headline": "Nektar Gears Up to Report Q2 Earnings: What's in the Cards?",
    "summary": "NKTR is due to report second-quarter results. Investors await fresh updates on rezpeg's progress across autoimmune trials.",
    "url": "https://finnhub.io/api/news?id=ffb4cccad2e2554308f5996991e11b194a5ea9a5698b07e4fefcbe7cceb825ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754322900,
      "headline": "Nektar Gears Up to Report Q2 Earnings: What's in the Cards?",
      "id": 136200226,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "NKTR is due to report second-quarter results. Investors await fresh updates on rezpeg's progress across autoimmune trials.",
      "url": "https://finnhub.io/api/news?id=ffb4cccad2e2554308f5996991e11b194a5ea9a5698b07e4fefcbe7cceb825ce"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?",
    "summary": "NVO's second-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, Wegovy, Ozempic and Rybelsus.",
    "url": "https://finnhub.io/api/news?id=0eac8f187113e1b78efd6b7fc662d8d0b1ac7154585942624f8832fb1cd705c6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754322540,
      "headline": "Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?",
      "id": 136200227,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "NVO's second-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, Wegovy, Ozempic and Rybelsus.",
      "url": "https://finnhub.io/api/news?id=0eac8f187113e1b78efd6b7fc662d8d0b1ac7154585942624f8832fb1cd705c6"
    }
  },
  {
    "ts": null,
    "headline": "Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?",
    "summary": "Let's look at five pharma and biotech companies, PFE, LLY, AMGN, GILD and NVO, which are scheduled to release their second-quarter 2025 results this week.",
    "url": "https://finnhub.io/api/news?id=883190f0e2f70a7ee2c2c89d4029b1a0d3a68266fb7467a0b0963edd4dee601a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754322480,
      "headline": "Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?",
      "id": 136200228,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Let's look at five pharma and biotech companies, PFE, LLY, AMGN, GILD and NVO, which are scheduled to release their second-quarter 2025 results this week.",
      "url": "https://finnhub.io/api/news?id=883190f0e2f70a7ee2c2c89d4029b1a0d3a68266fb7467a0b0963edd4dee601a"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Dow, S&P 500, Nasdaq climb in bounce back from Friday sell-off",
    "summary": "US stock futures were little changed following a week of sharp declines.",
    "url": "https://finnhub.io/api/news?id=783c0520042885dc429e1ff2b9205739acc8a40a97cc878067a248899377fd48",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754314303,
      "headline": "Stock market today: Dow, S&P 500, Nasdaq climb in bounce back from Friday sell-off",
      "id": 136197815,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "US stock futures were little changed following a week of sharp declines.",
      "url": "https://finnhub.io/api/news?id=783c0520042885dc429e1ff2b9205739acc8a40a97cc878067a248899377fd48"
    }
  },
  {
    "ts": null,
    "headline": "Insights Into Lilly (LLY) Q2: Wall Street Projections for Key Metrics",
    "summary": "Get a deeper insight into the potential performance of Lilly (LLY) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.",
    "url": "https://finnhub.io/api/news?id=25b916d5163fb6047eaa1861705477413fd1481635df9a6e4780c2af74105e77",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754313310,
      "headline": "Insights Into Lilly (LLY) Q2: Wall Street Projections for Key Metrics",
      "id": 136200229,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Get a deeper insight into the potential performance of Lilly (LLY) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.",
      "url": "https://finnhub.io/api/news?id=25b916d5163fb6047eaa1861705477413fd1481635df9a6e4780c2af74105e77"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly and Company (LLY) Slid Despite Strong Top-Line Growth",
    "summary": "RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here. U.S. equity markets surged in the second quarter, with the S&P 500 Total Return Index rising 10.94% and the Russell 1000 […]",
    "url": "https://finnhub.io/api/news?id=1d48fcf4eb183838dd44ced0a6fff799d80f09baa4689cf9e43287e098d45cb0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754312165,
      "headline": "Eli Lilly and Company (LLY) Slid Despite Strong Top-Line Growth",
      "id": 136197843,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here. U.S. equity markets surged in the second quarter, with the S&P 500 Total Return Index rising 10.94% and the Russell 1000 […]",
      "url": "https://finnhub.io/api/news?id=1d48fcf4eb183838dd44ced0a6fff799d80f09baa4689cf9e43287e098d45cb0"
    }
  },
  {
    "ts": null,
    "headline": "Should You Buy, Sell or Hold Lilly Stock Ahead of Q2 Earnings?",
    "summary": "LLY eyes Q2 growth on Mounjaro and Zepbound momentum, but pricing pressure and rising competition test its edge.",
    "url": "https://finnhub.io/api/news?id=5d2a7ae056f56d649bbb42750ae6018544210afdfb90c38a18dfe408f6ece792",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754311020,
      "headline": "Should You Buy, Sell or Hold Lilly Stock Ahead of Q2 Earnings?",
      "id": 136199252,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "LLY eyes Q2 growth on Mounjaro and Zepbound momentum, but pricing pressure and rising competition test its edge.",
      "url": "https://finnhub.io/api/news?id=5d2a7ae056f56d649bbb42750ae6018544210afdfb90c38a18dfe408f6ece792"
    }
  },
  {
    "ts": null,
    "headline": "How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?",
    "summary": "AbbVie's Q2 results show Skyrizi and Rinvoq powering growth, offsetting Humira declines and lifting 2025 sales outlook.",
    "url": "https://finnhub.io/api/news?id=9c132eec1758bc3561b9be905e163bf9acfd270aee745dd8f37eab5499c6e846",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754309700,
      "headline": "How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?",
      "id": 136200231,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "AbbVie's Q2 results show Skyrizi and Rinvoq powering growth, offsetting Humira declines and lifting 2025 sales outlook.",
      "url": "https://finnhub.io/api/news?id=9c132eec1758bc3561b9be905e163bf9acfd270aee745dd8f37eab5499c6e846"
    }
  },
  {
    "ts": null,
    "headline": "Tariff latest, Rate cuts and big earnings: Three Things",
    "summary": "Join Ramzan Karmali as he opens up the week with the three things you need to know ahead of US market open, taking a look at the impact of the damaging US jobs report, the Fed Reserve rates debate and upcoming earnings from major companies such as Palantir (PLTR), Disney (DIS) and Eli Lilly (LLY).",
    "url": "https://finnhub.io/api/news?id=729678d111b5fe03eaec5990dc3e862084b3d1f43d45a076840003ffa493f147",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754309340,
      "headline": "Tariff latest, Rate cuts and big earnings: Three Things",
      "id": 136197844,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Join Ramzan Karmali as he opens up the week with the three things you need to know ahead of US market open, taking a look at the impact of the damaging US jobs report, the Fed Reserve rates debate and upcoming earnings from major companies such as Palantir (PLTR), Disney (DIS) and Eli Lilly (LLY).",
      "url": "https://finnhub.io/api/news?id=729678d111b5fe03eaec5990dc3e862084b3d1f43d45a076840003ffa493f147"
    }
  },
  {
    "ts": null,
    "headline": "This Biotech Stock Could Soar on Upcoming Clinical Data",
    "summary": "This weight loss drugmaker may be significantly undervalued right now.",
    "url": "https://finnhub.io/api/news?id=726160509fdccd50df5942ec3d8b2aaaa226437470c4272bf834a9b9a922dc8a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754306100,
      "headline": "This Biotech Stock Could Soar on Upcoming Clinical Data",
      "id": 136197845,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "This weight loss drugmaker may be significantly undervalued right now.",
      "url": "https://finnhub.io/api/news?id=726160509fdccd50df5942ec3d8b2aaaa226437470c4272bf834a9b9a922dc8a"
    }
  },
  {
    "ts": null,
    "headline": "Central Bank Outlook Lifts Wall Street Pre-Bell; Asia, Europe Up",
    "summary": "Wall Street futures pointed moderately higher pre-bell Monday as traders weighed odds that the Feder",
    "url": "https://finnhub.io/api/news?id=00f5597fd509970a0aa122ae34451d3f2c148ce5ac685713d4231e5e774389a4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754305852,
      "headline": "Central Bank Outlook Lifts Wall Street Pre-Bell; Asia, Europe Up",
      "id": 136197847,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Wall Street futures pointed moderately higher pre-bell Monday as traders weighed odds that the Feder",
      "url": "https://finnhub.io/api/news?id=00f5597fd509970a0aa122ae34451d3f2c148ce5ac685713d4231e5e774389a4"
    }
  },
  {
    "ts": null,
    "headline": "Lilly’s Push to $1 Trillion Derailed by Trade Risks and Obesity Drug Speedbumps",
    "summary": "(Bloomberg) -- A year ago, Eli Lilly & Co. was poised to become the first pharmaceutical company to register a trillion-dollar market valuation. It still hasn’t cracked that ceiling.Most Read from BloombergSeeking Relief From Heat and Smog, Cities Follow the WindChicago Curbs Hiring, Travel to Tackle $1 Billion Budget HoleNYC Mayor Adams Gives Bally’s Bronx Casino Plan a Second ChanceInstead, a series of weak earnings reports, a setback for its obesity drug and threats of sky-high tariffs have t",
    "url": "https://finnhub.io/api/news?id=898c354f6d01951df2f7b782b1f22cde1986fb5dca64e9e678dd3044db2963e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754305201,
      "headline": "Lilly’s Push to $1 Trillion Derailed by Trade Risks and Obesity Drug Speedbumps",
      "id": 136197848,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- A year ago, Eli Lilly & Co. was poised to become the first pharmaceutical company to register a trillion-dollar market valuation. It still hasn’t cracked that ceiling.Most Read from BloombergSeeking Relief From Heat and Smog, Cities Follow the WindChicago Curbs Hiring, Travel to Tackle $1 Billion Budget HoleNYC Mayor Adams Gives Bally’s Bronx Casino Plan a Second ChanceInstead, a series of weak earnings reports, a setback for its obesity drug and threats of sky-high tariffs have t",
      "url": "https://finnhub.io/api/news?id=898c354f6d01951df2f7b782b1f22cde1986fb5dca64e9e678dd3044db2963e7"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Is Now A Better Value Play Than Eli Lilly With Solid Upside",
    "summary": "Novo Nordisk is misunderstood by the market, creating a rare asymmetric value opportunity. Read why I rate NVO stock a Buy ahead of Q2 earnings.",
    "url": "https://finnhub.io/api/news?id=78ecb74fc2af184458fe43212271ecf7f3106297ff19a39b88f33a6defe89516",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754289907,
      "headline": "Novo Nordisk Is Now A Better Value Play Than Eli Lilly With Solid Upside",
      "id": 136197059,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2153927815/image_2153927815.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Novo Nordisk is misunderstood by the market, creating a rare asymmetric value opportunity. Read why I rate NVO stock a Buy ahead of Q2 earnings.",
      "url": "https://finnhub.io/api/news?id=78ecb74fc2af184458fe43212271ecf7f3106297ff19a39b88f33a6defe89516"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Global Life Sciences Fund Q2 2025 Commentary",
    "summary": "Janus Henderson reviews Q2 healthcare headwinds and standout biotech picks. Learn how the fund is navigating policy shifts and finding innovation upside.",
    "url": "https://finnhub.io/api/news?id=0b87039d99d7e9cf0a9a88ab06e6861b276113fa4e554693cfbacf40d7eb67b3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754288400,
      "headline": "Janus Henderson Global Life Sciences Fund Q2 2025 Commentary",
      "id": 136196996,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/172204552/image_172204552.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Janus Henderson reviews Q2 healthcare headwinds and standout biotech picks. Learn how the fund is navigating policy shifts and finding innovation upside.",
      "url": "https://finnhub.io/api/news?id=0b87039d99d7e9cf0a9a88ab06e6861b276113fa4e554693cfbacf40d7eb67b3"
    }
  },
  {
    "ts": null,
    "headline": "Protean Funds Scandinavia AB July 2025 Partner Letter",
    "summary": "Protean Funds Scandinavia AB July 2025 Partner Letter",
    "url": "https://finnhub.io/api/news?id=7107aa91e18b6273152e5a2f40bc94ee6d05c32ff8031f68f078ad1720e56592",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754274900,
      "headline": "Protean Funds Scandinavia AB July 2025 Partner Letter",
      "id": 136196266,
      "image": "",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=7107aa91e18b6273152e5a2f40bc94ee6d05c32ff8031f68f078ad1720e56592"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Dow, S&P 500, Nasdaq futures climb with tariffs and jobs data in focus",
    "summary": "US stock futures were little changed following a week of sharp declines.",
    "url": "https://finnhub.io/api/news?id=cf1db0662d0fbc132196fa3103d445b8e7b1f8a5fcc02133cbda61f20d52449c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754266753,
      "headline": "Stock market today: Dow, S&P 500, Nasdaq futures climb with tariffs and jobs data in focus",
      "id": 136195416,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "US stock futures were little changed following a week of sharp declines.",
      "url": "https://finnhub.io/api/news?id=cf1db0662d0fbc132196fa3103d445b8e7b1f8a5fcc02133cbda61f20d52449c"
    }
  }
]